Avanir Reports Positive Phase III Results For Zenvia In Diabetic Neuropathic Pain
This article was originally published in The Pink Sheet Daily
Executive Summary
Confirmatory Phase III trial for Zenvia in involuntary emotional expression disorder set to launch later this year.